In laboratories at the University of Oregon, scientists have reached 160 million years into the past to resurrect proteins from the earliest mammals — and some of these ancient molecules kill bacteria more effectively than the drugs we rely on today. The work centers on lactoferrin, an immune protein carried in breast milk and tears, and the antimicrobial peptide hidden within it that ruptures bacterial cell walls. By tracing the evolutionary history of this protein back to the common ancestor of all placental mammals, researchers are not merely studying the past — they are reading nature's lo
BioTechniques
· Aug 28, 2026
· health
· 3 min read
High
Sourcing: Verified
Ancient Lactoferrin Proteins Offer Blueprint for Next-Generation Antimicrobials
◉
Health & Medicine
8599 related articles
FDA Approves Pancreatic Cancer Drug That May Extend Patient Survival
CBS News · 100% match
Amivantamab-lazertinib combo outperforms standard care in high-risk EG…
News-Medical.net · 99% match
Shingles Vaccine Linked to Lower Dementia Risk in Older Adults
Google News · 99% match
Israel treats suspected first Ebola case as DRC outbreak spreads
The Times of Israel · 99% match
FDA approves first CRISPR gene-editing therapy for sickle cell disease
UPI News · 99% match
Related Coverage
The Guardian · Aug 28
H5 bird flu spreads to dolphins as Australia evacuates Antarctic researchers over mass seal death fears
A dolphin died from H5 bird flu in South Australia, the second native mammal species infected. Australia evacuated 24 re…
The Guardian · Aug 28 Japanese paramedics ask people to stop tidying their shoes during emergenciesKanazawa fire department urges residents not to tidy paramedics' shoes during emergencies, as repositioning footwear can…
Al Jazeera · Aug 28 Algeria mourns 12 dead as massive wildfire outbreak sweeps northeastern provincesOver 150 wildfires erupted across Algeria in a single day, killing 12 people across multiple provinces. Residents in Jij…
Al Jazeera · Aug 28 DRC launches Ebola vaccination drive with untested vaccine as outbreak spiralsThe DRC has begun vaccinating frontline healthcare workers against Ebola using a vaccine licensed for a different strain…
Bias & Framing
⚖
Science journalism article presents University of Oregon research on ancient lactoferrin proteins with minimal apparent bias, using standard research communication framing.
Bias Direction
center
Confidence
MED
Optimistic scientific discovery narrative with emphasis on potential future applications. Uses vivid language ('blast from the past,' 'boon') to engage readers while maintaining factual reporting of research findings.
blast from the past that may prove to be a boon
resurrected ancient proteins
astonishing 160 million years old
fortify their antimicrobial arsenals
Skeptical scientific voices questioning feasibility of translating ancient proteins to modern therapeutics
Timeline and realistic assessment of when/if this could reach clinical application
Competing research approaches or alternative antimicrobial strategies
Potential limitations or challenges in the ancestral reconstruction methodology
Industry or regulatory perspective on development pathway
Geopolitical Impact
🌎
University of Oregon researchers reconstructed 160-million-year-old lactoferrin proteins with antimicrobial properties to develop novel drugs against antibiotic-resistant bacteria, with potential global health implications.
Escalation Risk
low
Confidence
MED
Global
United States
European Union
Asia-Pacific
Developing nations with high antibiotic resistance rates
Advances in antimicrobial drug development could shift pharmaceutical leadership toward institutions and nations investing in synthetic biology and biotech innovation. Early-stage research advantage favors US-based institutions; future commercialization may influence biotech industry competition and healthcare sovereignty.
Similar to the penicillin discovery (1928) that revolutionized medicine and shifted pharmaceutical power dynamics toward Western nations; this represents incremental innovation rather than paradigm shift.
Economic Lens
📈
University of Oregon researchers reconstructed 160-million-year-old lactoferrin proteins with antimicrobial properties, potentially enabling development of novel drugs against antibiotic-resistant bacteria.
Market Signal
bullish
Confidence
MED
Pharmaceutical and biotechnology
Healthcare and medical devices
Contract research organizations
Diagnostic testing
Consumers could benefit from more effective treatments for antibiotic-resistant infections, potentially reducing healthcare costs and improving treatment outcomes for serious bacterial infections.
Regulatory agencies (FDA, EMA) may need to establish expedited approval pathways for novel antimicrobial peptides. Policy support for antimicrobial resistance research funding and intellectual property protections for biotech innovations may increase.